Belatacept: Good, but not good enough?

Progress in inflammatory myopathies: good but not good enough

During the past decade there have been remarkable achievements in the immunopathogenesis of the inflammatory myopathies that laid the grounds for more eVective therapeutic interventions. This editorial summarises where we stand today in our understanding of these disorders and their treatment, identifies key biological issues that need further study, and considers possibilities of applying new ...

New oral anticoagulants: good but not good enough!

In the recent article by the European Society of Cardiology Working Group on anticoagulants in heart disease (1), the authors describe in great clarity the emerging data regarding new anticoagulants for the treatment of nonvalvular atrial fibrillation. In the closing segment of conclusions and implications, the authors list their concerns regarding “scientific knowledge gaps” and the lack of cl...

Progress in inflammatory myopathies: good but not good enough.

New Oral Anticoagulants: Good but Not Good Enough!

In the recent article by the European Society of Cardiology Working Group on anticoagulants in heart disease (1), the authors describe in great clarity the emerging data regarding new anticoagulants for the treatment of nonvalvular atrial fibrillation. In the closing segment of conclusions and implications, the authors list their concerns regarding “scientific knowledge gaps” and the lack of cl...

Growth Is Good, but Is Not Enough to Improve Nutrition

While it is generally agreed that growth is a necessary precondition for reducing poverty, relatively little is known about the relationship between economic growth and nutrition and, hence, how economic policies can be leveraged to improve nutrition. This chapter argues that growth is good, but is not enough to improve nutrition. During the early stages of development, growth helps reduce the ...